Correlation Between PT Hetzer and PT Chemstar
Can any of the company-specific risk be diversified away by investing in both PT Hetzer and PT Chemstar at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PT Hetzer and PT Chemstar into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PT Hetzer Medical and PT Chemstar Indonesia, you can compare the effects of market volatilities on PT Hetzer and PT Chemstar and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PT Hetzer with a short position of PT Chemstar. Check out your portfolio center. Please also check ongoing floating volatility patterns of PT Hetzer and PT Chemstar.
Diversification Opportunities for PT Hetzer and PT Chemstar
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between MEDS and CHEM is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding PT Hetzer Medical and PT Chemstar Indonesia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PT Chemstar Indonesia and PT Hetzer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PT Hetzer Medical are associated (or correlated) with PT Chemstar. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PT Chemstar Indonesia has no effect on the direction of PT Hetzer i.e., PT Hetzer and PT Chemstar go up and down completely randomly.
Pair Corralation between PT Hetzer and PT Chemstar
If you would invest 5,000 in PT Hetzer Medical on October 11, 2024 and sell it today you would earn a total of 0.00 from holding PT Hetzer Medical or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
PT Hetzer Medical vs. PT Chemstar Indonesia
Performance |
Timeline |
PT Hetzer Medical |
PT Chemstar Indonesia |
PT Hetzer and PT Chemstar Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with PT Hetzer and PT Chemstar
The main advantage of trading using opposite PT Hetzer and PT Chemstar positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PT Hetzer position performs unexpectedly, PT Chemstar can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PT Chemstar will offset losses from the drop in PT Chemstar's long position.PT Hetzer vs. Bangun Karya Perkasa | PT Hetzer vs. PT Dewi Shri | PT Hetzer vs. PT Sari Kreasi | PT Hetzer vs. PT Kusuma Kemindo |
PT Chemstar vs. PT Hetzer Medical | PT Chemstar vs. Bangun Karya Perkasa | PT Chemstar vs. PT Dewi Shri | PT Chemstar vs. PT Sari Kreasi |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Transaction History View history of all your transactions and understand their impact on performance | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |